首页> 外国专利> PHARMACEUTICAL DOSAGE FORM WITH MULTIPLE COATINGS FOR REDUCED IMPACT OF COATING FRACTURES

PHARMACEUTICAL DOSAGE FORM WITH MULTIPLE COATINGS FOR REDUCED IMPACT OF COATING FRACTURES

机译:具有多种涂层的制药剂量形式,可减少涂层断裂的影响

摘要

The present invention relates to a pharmaceutical composition in a solid unit dosage form for oral administration in a human or lower animal comprising: a. a safe and effective amount of a therapeutically active agent; b. an inner coating layer selected from the group consisting of poly(methacrylic acid, methyl methacrylate) 1:2, poly(methacrylic acid, methyl methacrylate) 1:1, and mixtures thereof; and c. an outer coating layer comprising an enteric polymer or film coating material; wherein the inner coating layer is not the same as the outer coating layer; wherein if the inner coating layer is poly(methacrylic acid, methyl methacrylate) 1:1 then the outer coating layer is not poly(methacrylic acid, methyl methacrylate) 1:2 or is not a mixture of poly(methacrylic acid, methyl methacrylate) 1:1 and poly(methacrylic acid, methyl methacrylate) 1:2; and wherein the inner coating layer and the outer coating layer do not contain any therapeutically active agent. This invention further relates to a method of maintaining the desired site of delivery of a therapeutic agent in the gastrointestinal tract by administering the above compositions to a human or lower animal.
机译:本发明涉及用于在人或低等动物中口服施用的固体单位剂型的药物组合物,其包含:a。安全有效量的治疗活性剂; b。内涂层选自聚(甲基丙烯酸,甲基丙烯酸甲酯)1∶2,聚(甲基丙烯酸,甲基丙烯酸甲酯)1∶1,以及它们的混合物。和c。外涂层,其包含肠溶聚合物或薄膜包衣材料;其中内涂层与外涂层不同;其中,如果内涂层是聚(甲基丙烯酸,甲基丙烯酸甲酯)1:1,则外涂层不是聚(甲基丙烯酸,甲基丙烯酸甲酯)1:2或不是聚(甲基丙烯酸,甲基丙烯酸甲酯)的混合物1:1和聚(甲基丙烯酸,甲基丙烯酸甲酯)1:2;并且其中内涂层和外涂层不包含任何治疗活性剂。本发明还涉及一种通过对人或低等动物给药上述组合物来维持治疗剂在胃肠道中期望的递送部位的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号